These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38611660)

  • 41. Comparative analysis of imaging and pathology features of mucinous carcinoma of the breast.
    Zhang L; Jia N; Han L; Yang L; Xu W; Chen W
    Clin Breast Cancer; 2015 Apr; 15(2):e147-54. PubMed ID: 25523373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long-term follow-up.
    Lashen AG; Toss MS; Mongan NP; Green AR; Rakha EA
    Cancer; 2023 Apr; 129(8):1183-1194. PubMed ID: 36653923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlations between apparent diffusion coefficient in diffusion?weighted magnetic resonance imaging and molecular subtypes of invasive breast cancer masses].
    Shang LT; Yang JF; Lu J; Wang TT; Zhou Y; Xing XB; Wang XK; Yang SH; Hu MY
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Oct; 37(10):1410-1414. PubMed ID: 29070476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
    Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
    Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.
    Navarro Vilar L; Alandete Germán SP; Medina García R; Blanc García E; Camarasa Lillo N; Vilar Samper J
    Breast J; 2017 Jul; 23(4):421-428. PubMed ID: 28067435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography?
    Kamal RM; Helal MH; Mansour SM; Haggag MA; Nada OM; Farahat IG; Alieldin NH
    Br J Radiol; 2016 Aug; 89(1064):20160157. PubMed ID: 27327403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
    Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
    Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast imaging reporting and data system (BI-RADS) lexicon for breast MRI: interobserver variability in the description and assignment of BI-RADS category.
    El Khoury M; Lalonde L; David J; Labelle M; Mesurolle B; Trop I
    Eur J Radiol; 2015 Jan; 84(1):71-76. PubMed ID: 25454100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging.
    Torous VF; Resteghini NA; Phillips J; Dialani V; Slanetz PJ; Schnitt SJ; Baker GM
    Arch Pathol Lab Med; 2021 Oct; 145(10):1264-1269. PubMed ID: 33450753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [MRI findings and pathological features of occult breast cancer].
    Zhang JJ; Yang XT; Du XS; Zhang JX; Hou LN; Niu JL
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):40-45. PubMed ID: 29365416
    [No Abstract]   [Full Text] [Related]  

  • 52. Categorization of non-mass-like breast lesions detected by MRI.
    Sakamoto N; Tozaki M; Higa K; Tsunoda Y; Ogawa T; Abe S; Ozaki S; Sakamoto M; Tsuruhara T; Kawano N; Suzuki T; Yamashiro N; Fukuma E
    Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features.
    Alikhassi A; Li X; Au F; Kulkarni S; Ghai S; Allison G; Freitas V
    Breast Cancer Res Treat; 2023 Apr; 198(2):321-334. PubMed ID: 36740611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
    Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
    Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of an MRI/US fusion technique for the detection of non-mass enhancement of breast lesions detected by MRI yet occult on conventional B-mode second-look US.
    Goto M; Nakano S; Saito M; Banno H; Ito Y; Ido M; Ando T; Kousaka J; Fujii K; Suzuki K
    J Med Ultrason (2001); 2022 Apr; 49(2):269-278. PubMed ID: 35083535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy.
    Jun S; Bae SJ; Cha YJ; Cha C; Park S; Kim D; Lee J; Ahn SG; Son EJ; Jeong J
    Clin Breast Cancer; 2020 Aug; 20(4):e458-e468. PubMed ID: 32201166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.
    Nguyen DL; Lotfalla M; Cimino-Mathews A; Habibi M; Ambinder EB
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230060. PubMed ID: 38305717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.